BOT
BOTANIX FPO [BOT]
Healthcare · ASX Small Cap
$0.0210 +0.0%
Updated 3 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when BOT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- Low cash runway (2 quarters) - dilution risk
- Low P/S ratio (1.7x)
- Strong revenue growth (+220%)
- Near 52-week low (2% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (10%)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 82% over the past year
- Poor risk-adjusted returns — Sharpe of -2.1 means lots of volatility for not much reward
- Revenue growing at +220% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.44%/day)
- Low-priced stock risk ($0.021)
- Beneish M-Score 1.20 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-206%)
- Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about BOT
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Change of Director's Interest Notice
NONE Notification of cessation of securities - BOT
NONE Appendix 4G and Corporate Governance Statement
LOW Appendix 4E & Annual Report for the Year Ended 30 June 2026
Recent ASX Announcements
| 2026-08-31 | Change of Director's Interest Notice |
| 2026-08-31 | Notification of cessation of securities - BOT |
| 2026-08-26 | Appendix 4G and Corporate Governance Statement |
| 2026-08-26 | Appendix 4E & Annual Report for the Year Ended 30 June 2026 PRICE SENSITIVE |
| 2026-08-14 | Notification regarding unquoted securities - BOT |
Key Metrics
$57.5M
Market Cap
5.5M
Avg Volume
1.0x
Vol Ratio
$0.02 — $0.17
52-Week Range
0.7%
Short Interest
N/A
Cash Runway
-96.4%
ROE
-206.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 96% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | pass | Inst: 10% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track BOT and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required